Skip to main content
. Author manuscript; available in PMC: 2021 Jan 27.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 Jan 8;29(3):650–658. doi: 10.1158/1055-9965.EPI-19-1212

Table 2.

Baseline and demographic characteristics of the study population selected from the Golestan Cohort participants

Opiate non-users
Opiate users
Never tobacco users (n=58)* Cigarette smokers (n=33)* Total (n=91) Exclusive opiate users (n=23)* Users of opiate and
cigarette
(n=30)
Total (n=53)

Age: mean (SD) 51.2(8.4) 50.7(7.6) 51.0 (8.1) 50.4(5.3) 48.2(6.9) 49.2 (6.3)
Sex: m/f 28/30 33/0 61/30 23/0 30/0 53/0
Turkmen ethnicity % 70.7 72.7 71.4 100 86.7 92.5
Residence
 Urban: % 19.0 42.4 27.5 4.3 20 13.2
 Rural: % 81.0 57.6 72.5 95.7 80 86.8
education
 None: % 63.8 39.4 55.0 52.2 56.7 54.7
 1–8 years: % 25.9 30.3 27.5 34.8 23.3 28.3
 > 8 years: % 10.3 30.3 17.5 13.0 20.0 17.0
BMI
Underweight: % 1.8 0 1.1 4.3 16.7 11.3
 Normal: % 31.0 42.4 35.2 26.1 70 51.0
 Overweight: % 36.2 39.4 37.4 60.9 13.3 34.0
 Obese: % 31.0 18.2 26.4 8.7 0 3.7
Age when use started: mean (SD)
 Tobacco NA 25.2(7.4) 25.2(7.4) NA 27.2(11.1) 27.2(11.1)
 Opiate NA NA NA 45.2(7.2) 35.4(8.0) 39.7 (9.0)
Use intensity: mean per day (SD)
 Cigarette NA 10.9(7.3) NA NA 16.4(8.9) NA
 Opiate NA NA NA 3.5(2.7) 4.7 (3.4) 4.2 (3.2)
*

Numbers exclude individuals who had self-reported tobacco status discordant with measured cotinine concentrations